Literature DB >> 17311561

Ligand-based drug design methodologies in drug discovery process: an overview.

Magdalena Bacilieri1, Stefano Moro.   

Abstract

Ligand-based drug design represents an important research field in the drug discovery and optimisation process. This review provides an overview about the theoretical background of the quantitative structure activity relationship (QSAR) models.

Mesh：

Substances：

Year:  2006        PMID： 17311561     DOI： 10.2174/157016306780136781

Source DB:  PubMed          Journal:  Curr Drug Discov Technol        ISSN： 1570-1638


  5 in total

Review 1.  Generative chemistry: drug discovery with deep learning generative models.

Authors:  Yuemin Bian; Xiang-Qun Xie
Journal:  J Mol Model       Date:  2021-02-04       Impact factor: 1.810

2.  In Silico Studies Targeting G-protein Coupled Receptors for Drug Research Against Parkinson's Disease.

Authors:  Agostinho Lemos; Rita Melo; Antonio Jose Preto; Jose Guilherme Almeida; Irina Sousa Moreira; Maria Natalia Dias Soeiro Cordeiro
Journal:  Curr Neuropharmacol       Date:  2018       Impact factor: 7.363

Review 3.  In Silico Strategies in Tuberculosis Drug Discovery.

Authors:  Stephani Joy Y Macalino; Junie B Billones; Voltaire G Organo; Maria Constancia O Carrillo
Journal:  Molecules       Date:  2020-02-04       Impact factor: 4.411

4.  [New strategies for the development of antiviral molecules].

Authors:  Guillaume Castel; Noël Tordo
Journal:  Rev Francoph Lab       Date:  2009-12-11

Review 5.  In silico Methods for Design of Kinase Inhibitors as Anticancer Drugs.

Authors:  Zarko Gagic; Dusan Ruzic; Nemanja Djokovic; Teodora Djikic; Katarina Nikolic
Journal:  Front Chem       Date:  2020-01-08       Impact factor: 5.221
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.